NewcelX Ltd. (NCEL) Stock Price

2.86 ▲ +0.03 (+1.06%)
Open: 2.81 Vol: 4.57K Day's range: 2.81 - 2.86 Mar 03, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
NCEL Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 2.86▼ 2.85▼ 2.85▼ 2.87▼ 2.80▲
MA10 2.78▲ 2.76▲ 2.76▲ 2.79▲ 2.59▲
MA20 2.74▲ 2.74▲ 2.74▲ 2.79▲ N/A    
MA50 2.78▲ 2.75▲ 2.73▲ 2.58▲ N/A    
MA100 2.70▲ 2.68▲ 2.65▲ N/A     N/A    
MA200 2.64▲ 2.73▲ N/A     N/A     N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD 0.017▲ 0.015▲ 0.013▲ 0.015▲ N/A    
RSI 53.403▲ 53.945▲ 53.336▲ 54.554▲ N/A    
STOCH 87.736▲ 75.236     75.236     66.392     N/A    
WILL %R -32.075     -32.075     -32.075     -42.500     -65.480    
CCI 40.366     57.301     57.622     59.013     28.558    
Latest Filters Detected On NCEL
▲ GAP $NCEL Open Gap Up %2 Set Alert
CDL $NCEL Engulfing Candlestick Pattern Detected Set Alert
CDL $NCEL Marubozu Candlestick Pattern Detected Set Alert
NewcelX Ltd. News
NewcelX Announces Updated Corporate Presentation Ahead of Key Spring 2026 Investor and Partnering Conferences
Wednesday, January 28, 2026 08:00 PM
ZURICH, Jan. 29, 2026 /PRNewswire/ -- NewcelX Ltd. (NASDAQ: NCEL) ("NewcelX" or the "Company"), a clinical-stage cell therapy company advancing transformative treatments for chronic metabolic and ...
NewcelX Announce Positive Results from International Collaborative Study Exploring Advanced Biomaterial Approaches for Stem Cell-Derived Islet Delivery in Type 1 Diabetes ...
Sunday, January 11, 2026 08:00 PM
ZURICH, Jan. 12, 2026 /PRNewswire/ -- NewcelX Ltd. (Nasdaq: NCEL) ("NewcelX" or the "Company"), a clinical-stage biotechnology company advancing regenerative medicine solutions, today reported the ...
NewcelX Strengthens Scientific Advisory Board with Appointment of Jeremy Shefner, MD, PhD, Chief Medical Officer at the Barrow Neurological Institute
Monday, November 17, 2025 04:01 AM
ZURICH and NESS ZIONA, Israel, Nov. 17, 2025 /PRNewswire/ -- NewcelX Ltd. (Nasdaq: NCEL) ("NewcelX" or "the Company"), a clinical-stage biotechnology company developing cell-based and small-molecule ...
NCEL historical stock data
date open high low close volume
03/03/26 2.81 2.86 2.81 2.86 4,567
02/03/26 2.98 2.98 2.83 2.83 2,424
27/02/26 2.84 2.91 2.83 2.90 2,701
26/02/26 2.82 2.95 2.82 2.87 3,899
25/02/26 2.76 2.88 2.76 2.88 5,296
24/02/26 2.79 2.79 2.65 2.71 4,378
23/02/26 2.68 2.77 2.63 2.645 7,092
20/02/26 2.75 2.82 2.67 2.70 15,900
19/02/26 2.71 2.76 2.70 2.76 7,200
18/02/26 2.70 2.74 2.67 2.71 12,600
Quote Details
52wk Low:1.89
52wk High:4.70
Vol:4.57K
Avg Vol(3m):1.6M
1Y Chng:+0.00%
1M Chng:+15.32%
Add to Watch List
More Information
Index US Composite
Market Cap. 12.90M